|
Avience Biomedicals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
136.03 Cr.
|
P/BV
|
6.19
|
Book Value (Rs.)
|
40.07
|
|
52 Week High/Low (Rs.)
|
415/222
|
FV/ML
|
10/600
|
P/E(X)
|
20.20
|
|
Bookclosure
|
|
EPS (Rs.)
|
12.28
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | 21.71 | 19.06 | 6.52 |
| Diluted EPS (Rs.) | 21.71 | 19.06 | 19.06 |
| Cash EPS (Rs.) | 24.74 | 20.07 | 8.40 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 77.92 | 56.50 | 18.91 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 77.92 | 56.50 | 18.91 |
| Revenue From Operations / Share (Rs.) | 130.25 | 112.21 | 72.96 |
| PBDIT / Share (Rs.) | 37.77 | 30.12 | 13.65 |
| PBIT / Share (Rs.) | 34.74 | 27.99 | 11.77 |
| PBT / Share (Rs.) | 30.92 | 24.31 | 8.97 |
| Net Profit / Share (Rs.) | 21.71 | 17.94 | 6.52 |
| NP After MI And SOA / Share (Rs.) | 21.71 | 17.94 | 6.52 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 29.00 | 26.84 | 18.71 |
| PBIT Margin (%) | 26.67 | 24.94 | 16.13 |
| PBT Margin (%) | 23.74 | 21.66 | 12.29 |
| Net Profit Margin (%) | 16.67 | 15.98 | 8.93 |
| NP After MI And SOA Margin (%) | 16.67 | 15.98 | 8.93 |
| Return on Networth / Equity (%) | 27.86 | 31.75 | 34.47 |
| Return on Capital Employeed (%) | 31.13 | 34.17 | 27.95 |
| Return On Assets (%) | 11.22 | 12.79 | 6.17 |
| Long Term Debt / Equity (X) | 0.42 | 0.43 | 1.17 |
| Total Debt / Equity (X) | 0.92 | 0.97 | 2.44 |
| Asset Turnover Ratio (%) | 0.78 | 0.99 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 1.41 | 1.58 | 1.11 |
| Quick Ratio (X) | 0.89 | 1.03 | 0.51 |
| Inventory Turnover Ratio (X) | 3.47 | 3.55 | 0.00 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 9.89 | 8.20 | 4.86 |
| Interest Coverage Ratio (Post Tax) (%) | 6.69 | 5.88 | 3.32 |
